Perspective Therapeutics (CATX) EPS (Basic) (2010 - 2026)

Perspective Therapeutics (CATX) posted EPS (Basic) of -$0.28 for Q1 2026, down 4132.2% sequentially from $0.01 in Q2 2025.

Perspective Therapeutics (CATX) EPS (Basic) (2010 - 2026) Analysis & Trends

Perspective Therapeutics has reported EPS (Basic) for 17 years, with the latest figure at -$0.28 in Q1 2026.

Quarterly EPS (Basic) changed N/A year-over-year to -$0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.27 (down 3949.44% YoY) and the FY2025 annual result came in at $0.01, up 147.27% from the prior year.
EPS (Basic) slipped to -$0.28 in Q1 2026 per CATX's latest filing, from $0.01 in the prior quarter.
Over five years, EPS (Basic) peaked at $0.01 in Q2 2025 and troughed at -$0.53 in Q3 2022.
A 5-year average of -$0.13 and a median of -$0.08 in 2022 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2022 and 2025: EPS (Basic) tumbled 233.69% in 2022, then surged 194.18% in 2025.
Over 5 years, EPS (Basic) stood at -$0.16 in 2022, then retreated by 20.93% to -$0.19 in 2023, then surged by 96.2% to -$0.01 in 2024, then soared by 194.18% to $0.01 in 2025, then sank by 4132.2% to -$0.28 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.28, $0.01, and -$0.01 for Q1 2026, Q2 2025, and Q2 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.53
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	3.33
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.98
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.42
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.65
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.06
10	Perspective Therapeutics	388.50 Mn	388.50 Mn	-	-0.22

Download Data